Global CRISPR-Based Therapeutics Market Research Report 2023

CRISPR-Based Therapeutics Market

CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.

The global CRISPR-Based Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for CRISPR-Based Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for CRISPR-Based Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for CRISPR-Based Therapeutics in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of CRISPR-Based Therapeutics include Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for CRISPR-Based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR-Based Therapeutics.

The CRISPR-Based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRISPR-Based Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR-Based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of CRISPR-Based Therapeutics Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Genome Editing

1.2.3 Genetic Engineering

1.2.4 gRNA Database/Gene Librar

1.2.5 CRISPR Plasmid

1.2.6 Human Stem Cells

1.2.7 Genetically Modified Organisms/Crops

1.2.8 Cell Line Engineering

1.3 Market by Application

1.3.1 Global CRISPR-Based Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Biotechnology Companies

1.3.3 Pharmaceutical Companies

1.3.4 Academic Institutes

1.3.5 Research and Development Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global CRISPR-Based Therapeutics Market Perspective (2018-2029)

2.2 CRISPR-Based Therapeutics Growth Trends by Region

2.2.1 Global CRISPR-Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 CRISPR-Based Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 CRISPR-Based Therapeutics Market Dynamics

2.3.1 CRISPR-Based Therapeutics Industry Trends

2.3.2 CRISPR-Based Therapeutics Market Drivers

2.3.3 CRISPR-Based Therapeutics Market Challenges

2.3.4 CRISPR-Based Therapeutics Market Restraints

3.1 Global Top CRISPR-Based Therapeutics Players by Revenue

3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2018-2023)

3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue

3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio

3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2022

3.5 CRISPR-Based Therapeutics Key Players Head office and Area Served

3.6 Key Players CRISPR-Based Therapeutics Product Solution and Service

3.7 Date of Enter into CRISPR-Based Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America CRISPR-Based Therapeutics Market Size (2018-2029)

6.2 North America CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America CRISPR-Based Therapeutics Market Size by Country (2018-2023)

6.4 North America CRISPR-Based Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe CRISPR-Based Therapeutics Market Size (2018-2029)

7.2 Europe CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023)

7.4 Europe CRISPR-Based Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific CRISPR-Based Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America CRISPR-Based Therapeutics Market Size (2018-2029)

9.2 Latin America CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023)

9.4 Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Caribou Biosciences

11.1.1 Caribou Biosciences Company Detail

11.1.2 Caribou Biosciences Business Overview

11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction

11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.1.5 Caribou Biosciences Recent Development

11.2 Addgene

11.2.1 Addgene Company Detail

11.2.2 Addgene Business Overview

11.2.3 Addgene CRISPR-Based Therapeutics Introduction

11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.2.5 Addgene Recent Development

11.3 CRISPR THERAPEUTICS

11.3.1 CRISPR THERAPEUTICS Company Detail

11.3.2 CRISPR THERAPEUTICS Business Overview

11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction

11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.3.5 CRISPR THERAPEUTICS Recent Development

11.4 Merck KGaA

11.4.1 Merck KGaA Company Detail

11.4.2 Merck KGaA Business Overview

11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction

11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.4.5 Merck KGaA Recent Development

11.5 Mirus Bio LLC

11.5.1 Mirus Bio LLC Company Detail

11.5.2 Mirus Bio LLC Business Overview

11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction

11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.5.5 Mirus Bio LLC Recent Development

11.6 Editas Medicine

11.6.1 Editas Medicine Company Detail

11.6.2 Editas Medicine Business Overview

11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction

11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.6.5 Editas Medicine Recent Development

11.7 Takara Bio USA

11.7.1 Takara Bio USA Company Detail

11.7.2 Takara Bio USA Business Overview

11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction

11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.7.5 Takara Bio USA Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Detail

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction

11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Horizon Discovery Group

11.9.1 Horizon Discovery Group Company Detail

11.9.2 Horizon Discovery Group Business Overview

11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction

11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.9.5 Horizon Discovery Group Recent Development

11.10 Intellia Therapeutics

11.10.1 Intellia Therapeutics Company Detail

11.10.2 Intellia Therapeutics Business Overview

11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction

11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.10.5 Intellia Therapeutics Recent Development

11.11 GE Healthcare Dharmacon

11.11.1 GE Healthcare Dharmacon Company Detail

11.11.2 GE Healthcare Dharmacon Business Overview

11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction

11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023)

11.11.5 GE Healthcare Dharmacon Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Genome Editing

    Table 3. Key Players of Genetic Engineering

    Table 4. Key Players of gRNA Database/Gene Librar

    Table 5. Key Players of CRISPR Plasmid

    Table 6. Key Players of Human Stem Cells

    Table 7. Key Players of Genetically Modified Organisms/Crops

    Table 8. Key Players of Cell Line Engineering

    Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global CRISPR-Based Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global CRISPR-Based Therapeutics Market Share by Region (2018-2023)

    Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global CRISPR-Based Therapeutics Market Share by Region (2024-2029)

    Table 15. CRISPR-Based Therapeutics Market Trends

    Table 16. CRISPR-Based Therapeutics Market Drivers

    Table 17. CRISPR-Based Therapeutics Market Challenges

    Table 18. CRISPR-Based Therapeutics Market Restraints

    Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2018-2023)

    Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)

    Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players CRISPR-Based Therapeutics Product Solution and Service

    Table 26. Date of Enter into CRISPR-Based Therapeutics Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2023)

    Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2024-2029)

    Table 32. Global CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2023)

    Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2024-2029)

    Table 36. North America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America CRISPR-Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe CRISPR-Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific CRISPR-Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Caribou Biosciences Company Detail

    Table 52. Caribou Biosciences Business Overview

    Table 53. Caribou Biosciences CRISPR-Based Therapeutics Product

    Table 54. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 55. Caribou Biosciences Recent Development

    Table 56. Addgene Company Detail

    Table 57. Addgene Business Overview

    Table 58. Addgene CRISPR-Based Therapeutics Product

    Table 59. Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 60. Addgene Recent Development

    Table 61. CRISPR THERAPEUTICS Company Detail

    Table 62. CRISPR THERAPEUTICS Business Overview

    Table 63. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product

    Table 64. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 65. CRISPR THERAPEUTICS Recent Development

    Table 66. Merck KGaA Company Detail

    Table 67. Merck KGaA Business Overview

    Table 68. Merck KGaA CRISPR-Based Therapeutics Product

    Table 69. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 70. Merck KGaA Recent Development

    Table 71. Mirus Bio LLC Company Detail

    Table 72. Mirus Bio LLC Business Overview

    Table 73. Mirus Bio LLC CRISPR-Based Therapeutics Product

    Table 74. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 75. Mirus Bio LLC Recent Development

    Table 76. Editas Medicine Company Detail

    Table 77. Editas Medicine Business Overview

    Table 78. Editas Medicine CRISPR-Based Therapeutics Product

    Table 79. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 80. Editas Medicine Recent Development

    Table 81. Takara Bio USA Company Detail

    Table 82. Takara Bio USA Business Overview

    Table 83. Takara Bio USA CRISPR-Based Therapeutics Product

    Table 84. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 85. Takara Bio USA Recent Development

    Table 86. Thermo Fisher Scientific Company Detail

    Table 87. Thermo Fisher Scientific Business Overview

    Table 88. Thermo Fisher Scientific CRISPR-Based Therapeutics Product

    Table 89. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 90. Thermo Fisher Scientific Recent Development

    Table 91. Horizon Discovery Group Company Detail

    Table 92. Horizon Discovery Group Business Overview

    Table 93. Horizon Discovery Group CRISPR-Based Therapeutics Product

    Table 94. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 95. Horizon Discovery Group Recent Development

    Table 96. Intellia Therapeutics Company Detail

    Table 97. Intellia Therapeutics Business Overview

    Table 98. Intellia Therapeutics CRISPR-Based Therapeutics Product

    Table 99. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 100. Intellia Therapeutics Recent Development

    Table 101. GE Healthcare Dharmacon Company Detail

    Table 102. GE Healthcare Dharmacon Business Overview

    Table 103. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product

    Table 104. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 105. GE Healthcare Dharmacon Recent Development

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global CRISPR-Based Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global CRISPR-Based Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Genome Editing Features

    Figure 4. Genetic Engineering Features

    Figure 5. gRNA Database/Gene Librar Features

    Figure 6. CRISPR Plasmid Features

    Figure 7. Human Stem Cells Features

    Figure 8. Genetically Modified Organisms/Crops Features

    Figure 9. Cell Line Engineering Features

    Figure 10. Global CRISPR-Based Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global CRISPR-Based Therapeutics Market Share by Application: 2022 VS 2029

    Figure 12. Biotechnology Companies Case Studies

    Figure 13. Pharmaceutical Companies Case Studies

    Figure 14. Academic Institutes Case Studies

    Figure 15. Research and Development Institutes Case Studies

    Figure 16. CRISPR-Based Therapeutics Report Years Considered

    Figure 17. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global CRISPR-Based Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global CRISPR-Based Therapeutics Market Share by Region: 2022 VS 2029

    Figure 20. Global CRISPR-Based Therapeutics Market Share by Players in 2022

    Figure 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2022

    Figure 23. North America CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America CRISPR-Based Therapeutics Market Share by Country (2018-2029)

    Figure 25. United States CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe CRISPR-Based Therapeutics Market Share by Country (2018-2029)

    Figure 29. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. France CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Nordic Countries CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2018-2029)

    Figure 37. China CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. India CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America CRISPR-Based Therapeutics Market Share by Country (2018-2029)

    Figure 45. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2018-2029)

    Figure 49. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 52. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 53. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 54. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 55. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 56. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 57. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 59. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 60. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 61. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed